Overview

* Tactile Systems ( TCMD ) Q2 revenue rises 7.8% yr/yr, beating analyst expectations, per LSEG data

* Adjusted EBITDA for Q2 beats estimates, reaching $7.7 mln

* Net income declines to $3.2 mln from $4.3 mln in Q2 2024

Outlook

* Company expects 2025 revenue between $310 mln and $315 mln

* Tactile Systems ( TCMD ) projects 2025 adjusted EBITDA of $33 mln to $35 mln

* Company sees 2025 revenue growth of 6% to 8% year-over-year

* Tactile Systems ( TCMD ) anticipates strategic investments to benefit results in 2026

Result Drivers

* AIRWAY CLEARANCE SALES - 52% increase in sales driven by AffloVest placements among durable medical equipmentDME) partners

* LYMPHEDEMA PRODUCTIVITY - 2% revenue growth attributed to increased field sales team headcount and productivity

* LOWER COSTS - Gross profit rise due to reduced manufacturing and warranty costs

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $78.90 $73.90

Revenue mln mln (5

Analysts

)

Q2 EPS $0.14

Q2 Net $3.20

Income mln

Q2 Beat $7.70 $7.39

Adjusted mln mln (3

EBITDA Analysts

)

Q2 $4.10

Operatin mln

g Income

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

* Wall Street's median 12-month price target for Tactile Systems Technology Inc ( TCMD ) is $13.00, about 25.8% above its August 1 closing price of $9.65

* The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 20 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)